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Petection of Transplant
oronary Artery Disease Using
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OBJECTIVES This study sought to determine whether multidetector computed tomography (MDCT) may
be able to detect occlusive coronary disease in transplanted hearts.
BACKGROUND In heart transplant recipients, asymptomatic coronary disease requiring frequent surveillance
commonly develops. Recent advancements in MDCT allow for noninvasive assessment of the
coronary vessels.
METHODS Electrocardiogram-gated contrast-enhanced MDCT scans (16 0.75-mm detectors, 420 ms
rotation, 100 ml contrast) with multisegment reconstruction were performed on 54 transplant
recipients within 6  11 days of quantitative coronary angiography (QCA). Heart rate at the
time of the scan was 90  11 beats/min. Coronary arterial segments 1.5 mm in diameter
were analyzed by independent investigators.
RESULTS There was a good correlation between MDCT and QCA percent stenosis (r  0.75, p 
0.01, SEE  15%). Of the 791 segments identified by QCA, 754 (95%) were analyzable by
MDCT. The sensitivity, specificity, and positive and negative predictive values of MDCT
compared with QCA for the detection of segments with significant (50%) stenosis were
86%, 99%, 81%, and 99%, respectively. The MDCT correctly identified 15 of the 16 (94%)
transplant patients classified by QCA as having occlusive coronary artery disease and 29 of the
37 patients without significant stenosis (78%). In 1 patient who received intravenous
beta-blockers, transient bradycardia requiring temporary pacing developed, but there were no
other complications.
CONCLUSIONS Detection of occlusive coronary disease in heart transplant recipients with elevated resting
heart rate by MDCT is feasible using multicycle reconstruction. The need for surveillance
invasive coronary angiography in transplant recipients might be mitigated by use of
MDCT. (J Am Coll Cardiol 2006;48:772–8) © 2006 by the American College of
ublished by Elsevier Inc. doi:10.1016/j.jacc.2006.04.082Cardiology Foundation
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ceart transplant therapy has resulted in a significant improve-
ent in the survival of patients with end-stage heart failure.
oronary disease is the leading cause of decreased survival after
he first year post-transplantation (1). Clinically, the develop-
ent of coronary disease can be insidious because of denerva-
ion of the heart after transplantation (2). Currently, most
nstitutions perform annual surveillance by conventional coro-
ary angiography (3,4). However, invasive coronary angiogra-
hy carries risks including stroke, myocardial infarction, and
ascular injury (5), and performing multiple procedures on
eart transplant recipients is associated with an increased rate
f these complications (6).
Recent advancements in multidetector computed tomog-
aphy (MDCT) with improved gantry speed and submilli-
eter spatial resolution have made it possible to visualize
he coronary arterial tree noninvasively (7,8). Additionally,
From the *Cleveland Clinic Foundation, Cleveland, Ohio; †Diagnostico Maipu,
an Isidro, Buenos Aires, Argentina; and the ‡Organ Transplant Division, Favaloro
oundation, Buenos Aires, Argentina. Drs. Carrascosa and Garcia receive research
rant support from Philips Medical Systems. This study was funded in part by a
leveland Clinic RPC grant and by Philips Medical Systems.o
Manuscript received December 15, 2005; revised manuscript received April 18,
006, accepted April 25, 2006.DCT angiography is capable of assessing both lumen size
nd the vessel wall characteristics, detecting both noncalci-
ed and calcified lesions (9,10). Temporal resolution of
urrent MDCT scanners using half-scan reconstruction is
ypically 188 to 210 ms, thus administration of beta-
lockers is often required to reduce heart rate and motion
rtifacts. Heart transplantation patients often have an ele-
ated heart rate and are relatively insensitive to beta-
lockade. Recent data, however, suggest that MDCT tem-
oral resolution may be improved using multisegment
econstruction (11). Accordingly, we conducted the present
tudy to determine the diagnostic accuracy of 16-slice
DCT using multisegment reconstruction for detecting
cclusive coronary disease and proliferative vessel wall
hanges in heart transplant recipients.
ETHODS
ifty-four consecutive heart transplant recipients (age 54 
1 years, 89% male) who were scheduled for surveillance
oronary angiography were recruited. Subjects with a history
f contrast allergy, diabetes, renal dysfunction (creatinine
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August 15, 2006:772–8 Transplant Coronary Disease and MDCTbove 1.5 mg/dl), atrial fibrillation, and pregnancy were
xcluded. Institutional review committees approved the
tudy, and all patients gave written consent. Blood pressure
nd heart rate were measured before and after each MDCT
tudy. Serum creatinine was measured immediately before
he MDCT and 3 to 7 days after invasive catheterization.
erious adverse events were monitored and defined as
llergic reaction to contrast resulting in hospital admission,
ersistent hypotension, bleeding requiring transfusion, ex-
ravasations, and increase in creatinine above 2.0 mg/dl.
Invasive coronary angiography was performed in a stan-
ard fashion and was evaluated using quantitative coronary
ngiography (QCA) by independent investigators blinded
o the MDCT results. A commercially available analysis
rogram (Inturis Suite 2.2, Philips Medical Systems, High-
and Heights, Ohio) was used. Results from the QCA were
sed as a gold standard. Only those segments that had a
iameter by QCA 1.5 mm at their origin were analyzed.
subset of the study population also underwent intravas-
ular ultrasound (IVUS) examination in the following stan-
ard fashion. All patients received aspirin 100 to 325
g/day and/or clopidogrel for at least 72 h, 70 IU/kg of
nfractionated heparin, and 0.2 mg of nitroglycerin intra-
rterially immediately before the procedure. The IVUS
tudies were performed under fluoroscopic guidance with an
ltra-cross 3.2-F, 30-MHz coronary imaging catheter, res-
lution 0.07/0.20 mm (Boston Scientific Corporation,
atick, Massachusetts). The IVUS catheters were advanced
ver a guidewire for each of the main coronary arteries and
ranches until a vessel diameter of 2 mm was reached.
ontinuous images were recorded as the catheter was
utomatically pulled back (0.5 mm/s) from the distal to the
ost proximal segments. The equipment gain and gray scale
ere kept constant to avoid variation. After the IVUS
rocedure, an additional dose of 0.2 mg nitroglycerin was
dministered intracoronarily to avoid coronary spasm. The
VUS images were analyzed off line, and cross-sectional
mages from MDCT and IVUS data sets were matched
ccording to the distance from the coronary ostia to ensure
hat identical segments and plaques were assessed. Two
ndependent investigators then performed separate analysis
f the MDCT (described in later text) and IVUS images. In
atients who underwent both IVUS and MDCT examina-
ion, we qualitatively recorded the presence or absence of
roliferative changes in the coronary arterial wall. We
xcluded those segments in which QCA showed a stenosis
Abbreviations and Acronyms
CI  confidence interval
CTA  computed tomographic angiography
IVUS  intravascular ultrasound
MDCT  multidetector computed tomography
QCA  quantitative coronary angiographyf 50% by QCA. MSpiral electrocardiogram (ECG)-gated contrast-enhanced
DCT coronary angiography was performed with 16-
etector MDCT scanners (Mx8000ID, Philips Medical Sys-
ems). The MDCT scan parameters included 140 kVp, 400
As, 0.75-mm slice thickness, 0.4-mm slice increment,
.42-s rotation time, 0.2 to 0.3 pitch. After a noncontrast
urvey scan, a total of 100 ml of nonionic iodinated contrast
edium (iopromide, iohexol, or ioversol 350 to 370 mg/dl)
as administered intravenously (4 ml/s) in the antecubital
ein using a power injector (Stellant, Medrad, Indianola,
ennsylvania). The scan was initiated 4 s after the contrast-
nhanced ascending aorta reached a target value of 150
ounsfield units (HU). The entire heart was imaged within
single breath-hold (20 to 30 s). After the scan, the desired
hases (typically between 40% to 50% or 70% to 80%)
ithin the RR interval were reconstructed using the syn-
hronized ECG signal and X-ray projection data. An
daptive multisegment reconstruction algorithm yielded
mages with temporal resolutions between 53 and 210 ms
12). The reconstructed images were transferred to a work-
tation for analysis (MxView, Philips Medical Systems).
oronary vessel analysis was done from both volume-
endered and curved multiplanar images by investigators
linded to the invasive angiographic results. Coronary
rterial segments of 1.5 mm in diameter by MDCT were
nalyzed for the presence of stenosis and defined as a
ercent diameter reduction in comparison with an adjacent
egment. The proposed American Heart Association clas-
ification was used for vessel segmental analysis (13).
Heart rate during MDCT was recorded, and heart rate
ariability was defined as the standard deviation of the
hange in the RR interval during scan time. Heart rate
ariability in transplant patients was compared with that of
atients without a heart transplant who underwent MDCT
ngiography during same study period.
Quantitative MDCT and QCA measurements of percent
tenosis were compared using linear regression analysis and
land-Altman analysis of agreement (14). Qualitative anal-
sis was performed to assess the accuracy of MDCT for
etecting significant stenosis (defined as 50% diameter
eduction). Performance characteristics were evaluated us-
ng: 1) segments, 2) vessels, and 3) patients as the unit of
nalysis. For vessel-based analysis, the coronary tree was
eparated into the left anterior descending, left circumflex
rtery, and right coronary artery territories. The left main
runk was assigned to both the left anterior descending and
he left circumflex territories. Vessels with 1 or more
bstructed segments were encoded as stenotic for compar-
son. In a similar manner, patients with 1 or more ob-
tructed segments were encoded as stenotic for patient-
ased analysis classification. All vessels and patients were
nalyzed even if they included segment(s) not visualized by
DCT. Nonvisualized segments were categorized as non-
tenotic by MDCT for this purpose. Sensitivity, specificity,
nd positive and negative predictive values (for QCA vs.DCT and IVUS vs. MDCT) are presented with their
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Transplant Coronary Disease and MDCT August 15, 2006:772–8stimated 95% confidence intervals. In 13 patients, interob-
erver variability of stenosis detection by MDCT was tested
y a second observer blinded to the measurements of the
rst observer. Interobserver variability was calculated as bias
the average difference between the readers) as well as the
verage absolute difference between the 2 readers. Finally, to
valuate whether overall quality of the computed tomo-
raphic angiography (CTA) study affected final results, we
erformed a multiple logistic regression. As predictor vari-
bles we used percent stenosis by CTA and the ratio
etween the number of visualized segments by CTA divided
y the total number of segments present (an indicator of
TA study quality). The dependent variable was the pres-
nce or absence of significant (50%) stenosis on QCA.
tatistical analysis was performed using MedCalc version
.1 (MedCalc Software, Mariakerke, Belgium), HyperStat
n-line (Houston, Texas), and Microsoft Excel 2003 anal-
sis tools (Microsoft, Seattle, Washington).
ESULTS
he average patient’s height and weight for the study group
ere 1.8  0.08 m and 91.8  15 kg. In 1 patient
acemaker-induced tachycardia developed at the time of the
DCT, and the patient was excluded from the study.
hree patients received intravenous metoprolol (10 to 20
g) before the procedure. In 1 patient, transient bradycar-
ia and hypotension requiring temporary pacing developed;
he other 2 showed no response. Our negative initial
xperience deterred us from further use of beta-blockers in
his study. No other serious adverse events were related to
DCT. Serum creatinine was 1.2  0.3 mg/dl immedi-
tely before MDCT and remained unchanged (1.2  04
g/dl) 2.8  2.2 days after coronary angiography. In only 2
atients did a transient increase in creatinine above 1.5
g/dl (highest measured 1.7 mg/dl) develop, subsequently
eturning to baseline values. The average radiation exposure
uring the MDCT scan was estimated at 10  2 mSv.
Heart rate was significantly higher in transplant patients
90  11 beats/min) compared with nontransplant controls
66  14 beats/min, p  0.001). Heart rate variability
uring scan time measured as the standard deviation of the
R interval was significantly lower in heart transplantation
atients compared with controls (32  40 ms vs. 83  70
s, p  0.001). The elevated heart rate was not found to
ignificantly affect image interpretability (Fig. 1). In this
tudy, reconstruction of the end-systolic phase was used in
6% of studies and of the mid-diastolic phase in 24%.
There were 791 segments with a diameter 1.5 mm as
efined by QCA. Of these, 754 were identified by MDCT.
hus, only 37 segments (5%) were excluded for analysis
ecause of poor vessel opacification (n  14), motion
rtifacts (n  22), or beam hardening artifact caused by
tent (n  1). Calcified plaques, when present, were
ypically discrete and did not interfere with visualization of
he lumen by MDCT. There were 51 segments classified as aving 50% stenosis by QCA. Of these, only 1 segment
as deemed not evaluable by MDCT, and 7 were incor-
ectly classified as nonstenotic. The MDCT correctly iden-
ified 703 of the 713 (99%) segments classified as nonste-
otic by QCA. There was a good correlation between
DCT and QCA percent stenosis (r  0.75, p  0.01,
tandard error of estimate  15%). Bland-Altman analysis
uggested that MDCT overestimated stenosis severity by
.8% (Fig. 2). For assessment of interobserver variability,
he average bias between 2 readers was 1.1  16.9% (p 
S when compared with 0), and the average absolute
ifference was 4.31%. By logistic regression analysis, only
ercent stenosis by CTA predicted a presence of significant
tenosis on QCA (p 0.001), whereas study quality had no
ffect (p  0.79).
Of the 159 vessels available, MDCT correctly identified
9 of the 30 (97%) vessels classified as having occlusive
isease by QCA, and 119 of the 129 (92%) nonstenotic
essels (Figs. 3 to 5). The prevalence of occlusive disease was
lightly higher in the left anterior descending (n  14) and
eft circumflex (n  11) compared with the right coronary
rtery (n  5) distribution. The MDCT correctly identified
5 of the 16 (94%) transplant patients classified by QCA as
aving occlusive coronary artery disease and 29 of the 37
atients without significant stenosis (78%). Total occlusion
as found in 11 vessels or 8 patients. The sensitivity,
pecificity, positive and negative predictive values for seg-
ent, and vessel- and patient-based evaluations are sum-
arized in Table 1.
A subset of patients (13) also underwent IVUS examination
long with QCA. In such patients, the accuracy of MDCT at
ualitatively identifying the coronary segments with prolifera-
ive changes was assessed (excluding the lesions with stenosis
igure 1. Volume-rendered contrast-enhanced multidetector computed
omographic image obtained from a heart transplant patient with an
verage heart rate of 106 beats/min.50%). A total of 154 segments (an average of 12 segments
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August 15, 2006:772–8 Transplant Coronary Disease and MDCTer patient) were analyzed. The MDCT correctly identified 49
f the 51 segments with proliferative changes and 90 of the 102
egments without the proliferative changes as identified by
VUS. The sensitivity, specificity, and positive and negative
redictive values are as follows: 96% (95% confidence interval
CI] 87% to 99%), 88% (95% CI 80% to 94%), 80% (95% CI
9% to 88%) and 98% (95% CI 92% to 99%), respectively.
iffuse wall thickening was detected in 53 segments (34%) by
VUS and 54 segments (35%) by MDCT. The sensitivity and
pecificity of MDCT for detecting abnormal wall thickening
ere 92% (95% CI 82% to 98%) and 95% (95% CI 89% to
8%).
ISCUSSION
nnual surveillance for coronary disease is of great impor-
ance to heart transplant recipients because development of
igure 2. Bland-Altman analysis comparing stenosis determined by inv
MDCT) angiography (CTA). The points that lie on the 2 diagonal line
o (0%) stenosis, whereas the other method is detecting a stenosis.
igure 3. Right coronary artery with evidence of diffuse vasculopathy. Bot
B and C) show moderate stenosis of the lumen in the proximal segment. Diffus
rojection (A) and cross-sectional (C) images (arrows).ccult coronary disease is a major cause of late mortality (1).
onventional coronary angiography carries high cost and
onsiderable inconvenience to the transplant recipient (6).
lthough the risk of adverse events is relatively small,
erious and potentially life-threatening sequelae may occur,
ncluding arrhythmia, stroke, coronary artery dissection, and
ccess site bleeding, for a total complication rate of 1.8%
nd a mortality rate of 0.1% (15). It would be of great
mportance to establish a noninvasive test that could reduce
he number of invasive procedures that each patient has to
ndergo. Several noninvasive tests, including exercise elec-
rocardiogram, radionuclide scintigraphy, exercise echocar-
iography, and dobutamine echocardiography, have
roven unsatisfactory as tools for the screening of coro-
ary artery disease when compared with coronary angiog-
aphy or IVUS (16).
coronary angiography (CA) and multidetector computed tomographic
oing upward and 1 going downward) correspond to 1 method identifying
sive angiography (A) and multidetector computed tomography (MDCT)asiveh inva
e thickening of the vessel wall is noted in the MDCT maximum-intensity
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Transplant Coronary Disease and MDCT August 15, 2006:772–8Recent improvements in contrast-enhanced MDCT imag-
ng allow for a noninvasive evaluation of both the lumen size of
he coronary artery and the vessel wall characteristics (7–9).
imited experience exists on how contrast-enhanced MDCT
an detect coronary artery disease in transplant recipients (17).
he MDCT was recently evaluated in a small feasibility study
n 8 children after heart transplantation. The MDCT could
etect coronary artery disease, but image quality was thought to
uffer from motion artifacts related to elevated heart rate (18).
n our study, subjects were also found to have an elevated heart
ate but without significant compromise to image interpret-
bility. Image quality of MDCT is limited with increasing
eart rate because of the limited temporal resolution imposed
y the gantry rotational speed. Traditionally beta-blockers are
sed to improve image quality. Only 2 patients received
eta-blockers in this study and showed no immediate response,
ut 1 had delayed symptomatic bradycardia. Although it was
nclear whether the use of metoprolol was related to brady-
ardia in this case, we elected to discontinue its use in the
emaining study subjects. Safety concerns have been raised
igure 4. Small calcified atherosclerotic plaque seen in the left main coron
inimal angiographic irregularities (B).Figure 5. Left anterior descending artery showing distal vessel narrowing (arrowsegarding the use of beta-blockers in some patients after
ardiac transplantation because the denervated hearts may be
argely dependent on circulating catecholamines to increase
ardiac output. Beta-blocker use has been incriminated as one
f the contributing risk factors for the hypotension, acidosis,
nd vasodilatation syndrome reported after transplantation
19). An alternative therapy for heart rate reduction might be
ondihydropyridine calcium channel antagonists, such as ve-
apamil (20), but this was not used in the current study.
espite the elevated heart rate during image acquisition, only
% of segments 1.5 mm were deemed not evaluable. This
ight be explained by several factors, including decreased heart
ate variability, use of end-systolic phase for reconstruction, and
specific gating algorithm that smoothes heart rate change
21). An elevated heart rate facilitates multisegment recon-
truction algorithms that can provide temporal resolution of 53
o 105 ms (12).
In our study design we restricted the analysis to segments
1.5 mm in diameter. This gives MDCT a value in
etecting the lesions that are of the greatest clinical signif-
tery (arrow) by multidetector computed tomography (A) in a patient with) by multidetector computed tomography (A) and invasive angiography (B).
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August 15, 2006:772–8 Transplant Coronary Disease and MDCTcance. Smaller vessels are not as well visualized, but as this
echnique evolves and spatial resolution improves, the ac-
uracy of detecting stenosis in smaller vessels will likely
mprove.
In our study population, densely calcified plaques were
ncommon. This finding may be unique to transplant
asculopathy and may explain why the number of segments
hat needed to be excluded for analysis in our study was
ignificantly lower than previously reported in nontrans-
lantation patients. One of the potential advantages of
DCT over invasive coronary angiography is its ability to
efine vessel wall characteristics (Figs. 3 to 5). Recent
tudies suggest that MDCT can establish and quantify with
easonable accuracy the presence of calcified as well as
oncalcified plaques. Intravascular ultrasound studies have
hown abnormal thickening of the vessel wall in transplant
asculopathy, even in the absence of angiographic abnor-
alities. Whether MDCT might replace IVUS in trans-
lantation patients remains to be determined.
tudy limitations. This study was limited to subjects
ith normal renal function because study patients also
ere scheduled to undergo invasive coronary angiogra-
hy. Renal insufficiency is common in heart transplanta-
ion patients. Multidetector computed tomography may
till be feasible in patients with mild renal insufficiency
ecause image quality has been obtained with a lower
ontrast dose (9).
Radiation with MDCT in our study is somewhat higher
han would be expected with conventional coronary angiog-
aphy. Prospective electrocardiographically guided X-ray
ose modulation could reduce significantly the total radia-
ion dose toward an equivalent dose used during invasive
oronary angiography (22).
A direct and comprehensive comparison with IVUS was
ot available in all patients because that was not the original
oal of the study. However, a subgroup analysis showed that
DCT has a high degree of accuracy in detecting prolif-
rative wall changes compared with IVUS. Although IVUS
as greater spatial and temporal resolution than MDCT, it
ts very costly and invasive, and its use is limited only
roximal segments. Studies with IVUS indicate that vascu-
opathy with wall thickening 0.5 mm could carry prog-
able 1. Diagnostic Accuracy of Multidetector Computed
omographic Angiography to Detect 50% Coronary
bstruction
Segments Vessels Patients
rue-positive 43 29 15
rue-negative 703 119 29
alse-positive 10 10 8
alse-negative 7 1 1
ensitivity* 86% (75–96) 97% (89–100) 94% (79–100)
pecificity* 99% (98–100) 92% (87–97) 79% (64–93)
ositive predictive value* 81% (70–92) 74% (59–88) 65% (44–86)
egative predictive value* 99% (98–100) 99% (97–100) 97% (89–100)
Percentages (95% confidence intervals).ostic significance (23,24). The slice thickness of 16-sliceDCT is 0.75 mm, limiting the detection of mild vascu-
opathy but not of moderate or severe vasculopathy. Spatial
esolution can be as low as 0.4 mm with the newer 64-slice
canners and will likely improve in the future.
In general, elevated heart rates would be considered a
imitation to MDCT imaging, but in this patient popula-
ion it seemed to facilitate multisegment imaging with
mproved temporal resolution. The expected motion arti-
acts accompanied by an elevated heart rate were also
ircumvented by use of an end-systolic phase rather than a
id-diastolic phase during reconstruction, as previously
escribed (25,26).
onclusions. Imaging of the coronary vessels in heart
ransplantation patients with 16-slice MDCT with adapta-
ive multisegment reconstruction, seems to be both feasible
nd safe, and should not be limited to patients with a low
eart rate. Our results indicate that MDCT detects signif-
cant coronary stenoses with excellent diagnostic accuracy.
n particular, the high negative predictive value makes
DCT ideal for screening. If vessel wall analysis with
ewer-generation MDCT proves to be clinically valuable,
DCT could also represent an alternative to IVUS in
atients with suspected transplant vasculopathy.
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